CWA
FLGT icon

Clearview Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Clearview Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$185 – 295
2023
Q2 		$185 Hold
5
– – ﹤0.01% 665
2023
Q1 		$156 Hold
5
– – ﹤0.01% 653
2022
Q4 		$149 Hold
5
– – ﹤0.01% 599
2022
Q3 		$0 Hold
5
– – ﹤0.01% 597
2022
Q2 		$0 Hold
5
– – ﹤0.01% 608
2022
Q1 		$0 Hold
5
– – ﹤0.01% 647
2021
Q4 		$1K Hold
5
– – ﹤0.01% 636
2021
Q3 		$0 Hold
5
– – ﹤0.01% 670
2021
Q2 		$0 Hold
5
– – ﹤0.01% 659
2021
Q1 		$0 Hold
5
– – ﹤0.01% 626
2020
Q4 		$0 Buy
+5
New +$209 ﹤0.01% 576

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clearview Wealth Advisors's FLGT Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 5 shares — an estimated $185 sold.

Clearview Wealth Advisors first reported a position in FLGT in Q4 2020 and held it in 11 quarters. The position peaked at $1K in Q4 2021. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 5 Fulgent Genetics shares in Q3 2023, an estimated $185.
  • Clearview Wealth Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's Fulgent Genetics position peaked at $1K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.